[HTML][HTML] Overview of the muscle cytoskeleton

CA Henderson, CG Gomez, SM Novak… - Comprehensive …, 2017 - ncbi.nlm.nih.gov
Cardiac and skeletal striated muscles are intricately designed machines responsible for
muscle contraction. Coordination of the basic contractile unit, the sarcomere, and the …

MyBP-C: one protein to govern them all

L Heling, MA Geeves, NM Kad - Journal of muscle research and cell …, 2020 - Springer
The heart is an extraordinarily versatile pump, finely tuned to respond to a multitude of
demands. Given the heart pumps without rest for decades its efficiency is particularly …

Programmable C: G to G: C genome editing with CRISPR-Cas9-directed base excision repair proteins

L Chen, JE Park, P Paa, PD Rajakumar… - Nature …, 2021 - nature.com
Many genetic diseases are caused by single-nucleotide polymorphisms. Base editors can
correct these mutations at single-nucleotide resolution, but until recently, only allowed for …

Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney

LV Wain, A Vaez, R Jansen, R Joehanes… - …, 2017 - Am Heart Assoc
Elevated blood pressure is a major risk factor for cardiovascular disease and has a
substantial genetic contribution. Genetic variation influencing blood pressure has the …

Rapid whole genome sequencing impacts care and resource utilization in infants with congenital heart disease

NM Sweeney, SA Nahas, S Chowdhury… - NPJ genomic …, 2021 - nature.com
Congenital heart disease (CHD) is the most common congenital anomaly and a major cause
of infant morbidity and mortality. While morbidity and mortality are highest in infants with …

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure …

RA de Boer, S Heymans, J Backs… - European journal of …, 2022 - Wiley Online Library
Genetic cardiomyopathies are disorders of the cardiac muscle, most often explained by
pathogenic mutations in genes encoding sarcomere, cytoskeleton, or ion channel proteins …

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

JA Stern, VN Rivas, JL Kaplan, Y Ueda, MS Oldach… - Scientific Reports, 2023 - nature.com
We sought to establish a large animal model of inherited hypertrophic cardiomyopathy
(HCM) with sufficient disease severity and early penetrance for identification of novel …

Contractile deficits in engineered cardiac microtissues as a result of MYBPC3 deficiency and mechanical overload

Z Ma, N Huebsch, S Koo, MA Mandegar… - Nature biomedical …, 2018 - nature.com
The integration of in vitro cardiac tissue models, human induced pluripotent stem cells
(hiPSCs) and genome-editing tools allows for the enhanced interrogation of physiological …

An update on MYBPC3 gene mutation in hypertrophic cardiomyopathy

BS Tudurachi, A Zăvoi, A Leonte, L Țăpoi… - International journal of …, 2023 - mdpi.com
Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited
cardiomyopathy that follows an autosomal dominant inheritance pattern. The majority of …

Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes

M Prondzynski, E Krämer, SD Laufer… - … Therapy-Nucleic Acids, 2017 - cell.com
Gene therapy is a promising option for severe forms of genetic diseases. We previously
provided evidence for the feasibility of trans-splicing, exon skipping, and gene replacement …